A new study — which represents the largest clinical experience of thrombolysis for stroke in patients taking antiplatelet therapy — suggests that the overall benefits of thrombolytic therapy may ...

To read this article for CME, click here. July 27, 2007 — Oral anticoagulants are superior to antiplatelet therapy for primary stroke prevention in patients with nonvalvular atrial fibrillation (AF), ...

High platelet reactivity persists in many patients receiving antiplatelet therapy for secondary prevention of ischaemic stroke. Patient-tailored antiplatelet therapy, guided by platelet function tests ...

HOUSTON, TX—Combining clopidogrel, aspirin, and dipyridamole does not prevent recurrent ischemic strokes or TIAs and increases bleeding when compared with either clopidogrel alone or aspirin plus ...

Please provide your email address to receive an email when new articles are posted on . The efficacy of dual antiplatelet therapy vs. aspirin in patients with stroke was similar when given less than ...

Stroke survivors taking a combination of the blood thinner cilostazol with aspirin or clopidogrel had a lower risk of ischemic stroke recurrence than those who received aspirin or clopidogrel alone, ...

An experimental compound inhibited clot formation without increased bleeding, a common side effect of current anticlotting therapies, in a phase I study. First-in-human study shows the anticlotting ...

For more than 10 years, the stroke research community has sought and investigated drugs that could enhance or strengthen the ...

In patients who present early with minor ischemic stroke or high-risk transient ischemic attack (TIA), treatment with dual antiplatelet therapy (DAPT) for 21 days, followed by clopidogrel alone out to ...

Despite evidence that starting two blood-thinning medications shortly after a minor stroke or a warning stroke (transient ischemic attack - TIA) may prevent a second – possibly more serious – ...

Please provide your email address to receive an email when new articles are posted on . Younger patients with a patent foramen ovale who have had a cryptogenic ischemic stroke should undergo PFO ...

Recently, the NDA for Sumecigrel Capsule (formerly known as Vicagrel), a Class 1 innovative antiplatelet drug developed by ...